Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950005-98-000319
Filing Date
1998-03-30
Accepted
1998-03-30 00:00:00
Documents
8
Period of Report
1997-12-31
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 10-K405 217008
2 CERTIFICATE OF AMENDMENT EX-3.4.2 4433
3 CERTIFICATE OF AMENDMENT EX-3.5.2 4435
4 STOCK PURCHASE AGEEMENT EX-10.32 42038
5 SUBSIDIARY OF THE COMPANY EX-21.1 234
6 CONSENT OF ERNST & YOUNG, LLP EX-23.1 731
7 FINANCIAL DATA SCHEDULE EX-27.0 2292
8 FINANCIAL DATA SCHEDULE EX-27.1 2745
  Complete submission text file 0000950005-98-000319.txt   276064
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 74545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

EIN.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-22570 | Film No.: 98579100
SIC: 2833 Medicinal Chemicals & Botanical Products